健康な参加者および患者で初めて実施された臨床試験
Eleanor A Lisbon1, R Clark Brown1, Andrew Redfern2
1Pfizer Inc, New York, New York, USA.
Clinical pharmacology and therapeutics
|September 2, 2025
まとめ
新種のヘモグロビン修正剤であるオシベロターは,状細胞疾患 (SCD) の治療に有望である. 初期試験では,SCDの患者では耐受性が良好で,有意な薬動学的効果を示しています.
科学分野:
- 薬理学について
- 血液学
- 臨床試験
背景:
- シークル細胞疾患 (SCD) は,異常なヘモグロビン (Hb) ポリメリゼーションによって特徴づけられる遺伝的血液疾患である.
- SCDの現在の治療には限界があり,新しい治療方法が必要です.
研究 の 目的:
- 健康な参加者およびSCDを有する参加者におけるオシベロターの安全性,薬理動力学 (PK),および薬理動力学 (PD) を評価する.
- 初期段階の臨床試験において,オシベロータの投与量反応と耐受性を評価する.
主な方法:
- 健康な被験者における単発増量および多発増量による第1相臨床試験 (N=129).
- 群体PKベースの適応設計を用いて,投与レジミンを決定した.
- SCDを患った小集団 (N=6) は,オシベロータを最大6週間投与した.
主要な成果:
- Osivelotorは,健康な患者とSCD患者の両方に一般的によく耐えました.
- 投与量に依存する PK 露出と Hb- 酸素親和の増加が観察されました.
- SCD患者では,Hb濃度の改善,低血解マーカー,および赤血球 (RBC) の変形性の増加が認められた.
結論:
- Osivelotorは一般的によく耐受され,1日1回投与で達成された曝露で有意な薬動学的活性を示します.
- これらの発見は,状細胞病の治療のためのオシベロータの臨床試験の継続を支持します.
関連する概念動画
01:10Pharmacokinetics: Overview
7.1K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
7.1K
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.5K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.5K
01:21Pharmacodynamics: Overview and Principles
2.0K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.0K
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
315
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
315
01:28Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
01:19Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983